BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Rapamycin
,
rs2230926
,
MDM2
,
nitric oxide metabolic process
,
Ischemia
,
Embryo
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
igiv c
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for igiv c
Explore Curated Studies Results
Literature
Most Relevant Literature
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with …
Electrophysiologic correlations with clinical outcomes in CIDP.
Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparati…
Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen…
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE tr…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%
A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis Exacerbations
Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravi…
A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myast…
Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ